Cian Healthcare Ltd — Updates, 24-06-2025: Company Update

Ref: Disclosure under Corporate Insolvency Resolution Process (CIRP) pursuant to Regulation 30 of

SEBI (Listing Obligations and Disclosure Requirements) read with Schedule III Part A, Para A

Regulations, 2015

Dear Sir/Madam,

Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and

Listing Regulations

Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (as amended by Circular No.

SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024), we, Cian Healthcare Limited

CompanyCOCf the Company,

convened its 13th meeting on Saturday, June 21, 2025, which commenced at 11:30 A.M. and

concluded at 03:00 P.M, and inter-alia considered the following matters:

----------------Page (0) Break----------------

Item No. Particulars

A. The matters discussed in the CoC meeting are as follows:

1. The Resolution Professional chaired the meeting of the CoC.

2. Quorum of the CoC meeting was ascertained, and roll call was undertaken for participants

attending through video conferencing or other audio-visual means.

3.

4. Waivers and concessions proposed under the resolution plan were discussed and deliberated

upon.

5. The draft Deed of Assignment was tabled for discussion.

6. The revised list of creditors was taken on record.

7. Process updates were provided by the Resolution Professional.

8. The CoC noted and approved the:

a) Audited Financial Results (Standalone) of the Company for the half-yearly and financial year

ended on March 31, 2025, along with the Audit Report issued by M/s. SSRCA & Co, the

Statutory Auditors of the Company; and

b) Audited Financial Statements (Standalone) of the Company for the financial year ended on

March 31, 2025, along with the Audit Report issued by M/s. SSRCA & Co, the Statutory

Auditors of the Company.

9. The CoC deliberated and took note of the reasons for the delay in filing the below:

a) Audited Financial Results (Consolidated) of the Company for the half-yearly and financial

year ended on March 31, 2025, along with the Audit Report issued by M/s. SSRCA & Co, the

Statutory Auditors of the Company; and

b) Audited Financial Statements (Consolidated) of the Company for the financial year ended

on March 31, 2025, along with the Audit Report issued by M/s. SSRCA & Co., the Statutory

Auditors of the Company.

The subsidiary of the company, Dr. Smith Biotech Private Limited itself is admitted under

CIRP, and the Chairman had asked for data from the Insolvency Resolution Professional of

Dr. Smith Biotech Private Limited. IRP informed that the handover of Dr. Smith Biotech

Private limited is still in process and we are yet to receive all the data and the information

from the Corporate Debtor.

9. The proposed composition of the Board of Directors, which will constitute the management of

the Company upon approval of the resolution plan, was noted.

10.

----------------Page (1) Break----------------

B.Listofissuestobevoteduponafterdiscussion:

1.

2.

3.

4.

-------------------------

Roshen Chordiya

Resolution Professional, in the Matter of Cian Healthcare Ltd

IBBI Registration No.: IBBI/IPA-001/IP-P02840/2023-2024/14347

(Email For Correspondence: cirp.cianhealthcare@gmail.com)

Address: 114, Solaris Hubtown, N. S. Phadke Marg,

Near East West Flyover, Andheri (E), Mumbai-400069)

Place: Pune

----------------Page (2) Break----------------